Cargando…
SYST-01 MULTI-INSTITUTIONAL RANDOMIZED TRIAL COMPARING CANCER STEM CELL-TARGETED VS PHYSICIAN-CHOICE TREATMENTS IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS (NCT03632135)
BACKGROUND: Clinical outcomes in patients with recurrent high-grade glioma (HGG) remain poor. Cancer stem cells (CSCs) have been implicated in metastasis, treatment resistance and recurrence of HHGs. We have shown in several clinical studies that anti-CSC-directed therapy provides benefits in many c...
Autores principales: | Sengupta, Soma, Ranjan, Tulika, Yu, Alexander, Howard, Candace, Chen, Ricky, Chaudahary, Rekha, Marko, Nicholas, Aregawi, Darit, Glantz, Michael, Glass, Jon, Green, Richard, Lu-Hemerson, Christine, Mammoser, Aaaron, Moulding, Hugh, Jubelirer, Steven, Schoroeder, Jason, Anderson, Mark, Chow, Frances, Lirette, Seth, Denning, Krista, Alberico, Anthony, Valluri, Jagan, Claudio, Pier Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354199/ http://dx.doi.org/10.1093/noajnl/vdac078.080 |
Ejemplares similares
-
Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial
por: Ranjan, Tulika, et al.
Publicado: (2023) -
Treatment of unmethylated MGMT-promoter recurrent glioblastoma with cancer stem cell assay-guided chemotherapy and the impact on patients’ healthcare costs
por: Ranjan, Tulika, et al.
Publicado: (2023) -
Syst
por: Vialettes, H
Publicado: (1971) -
Clinical relevance of cancer stem cell chemotherapeutic assay for recurrent ovarian cancer()
por: Howard, Candace M., et al.
Publicado: (2020) -
The SysteMHC Atlas project
por: Shao, Wenguang, et al.
Publicado: (2018)